Investor mix
3 investors on record; lead investors include Foresite Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |
Developer of small molecule therapies for unmet needs in immunology
3 investors on record; lead investors include Foresite Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 100% |